Rocket Pharmaceuticals (RCKT) Announces Update on FDA Review Timeline of KRESLADI for Treatment of Severe Leukocyte Adhesion Deficiency-I streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Analysts Set Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Target Price at $54 80 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
In this piece, we will take a look at the 15 best strong buy stocks to invest in. If you want to skip our overview of analyst ratings and the finance industry, then you can take a look at the 5 Best Strong Buy Stocks To Invest In. The financial services industry is one of […]
Clearstead Advisors LLC trimmed its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 29.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,095 shares of the biotechnology company’s stock after selling 862 shares during the period. Clearstead Advisors LLC’s holdings in […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald in a report released on Wednesday, Benzinga reports. They presently have a $65.00 price objective on the biotechnology company’s stock. Cantor Fitzgerald’s target price points to a potential upside of 122.76% from the stock’s current price. Several […]